phase readout
saveNCT07554924: A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd.. Phase: PHASE1. Conditions: Spinal Muscular Atrophy 1
view source ↗
comments(0)
5-min edit window · permanent after that